Catalyst Wire Dossier Catalyst Wire Dossier

Amturnide

aliskiren/amlodipine/hydrochlorothiazide · Novartis Pharmaceuticals Corp.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Amturnide, covering 2011-05-09 to 2011-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension [Phase 3]

See pricing